IncellDx
IncellDx, a California-based medical firm, develops and distributes diagnostic instruments for life-threatening diseases globally.
Founded
2009IncellDx, a California-based medical firm, develops and distributes diagnostic instruments for life-threatening diseases globally.
IncellDx, founded in Menlo Park, California, is dedicated to revolutionizing the field of molecular diagnostics. The company's core mission is to develop and distribute advanced diagnostic instruments that address life-threatening diseases such as cancer, hepatitis, cervical cancer, and organ transplant rejection. Utilizing innovative technologies like multiplex RNA in situ hybridization and multiplex protein detection, IncellDx aims to provide precise and comprehensive diagnostic solutions to healthcare providers worldwide.
Notable figures associated with IncellDx include prominent scientists and medical professionals who contribute to its cutting-edge research and development. The company has garnered attention from key investors in the medical technology sector, bolstering its growth and innovation. Among its significant achievements are the development of highly sensitive diagnostic tools that have improved disease detection and patient outcomes globally. IncellDx's impact is evident in its contribution to advancing personalized medicine and enhancing the accuracy of disease diagnostics.
Companies similar to IncellDx include CareDx, Source Precision Medicine, MultiplexDX and In Diagnostics.
IncellDx was founded in 2009.
IncellDx's headquarters is located in Menlo Park, CA, US.
IncellDx's most recent funding round was for $6M (USD) in May 2012.
As of May 14, 2012, IncellDx has disclosed funding of $9M (USD). Undisclosed round amounts are excluded.
IncellDx has 26 employees as of Feb 5, 2024.
In Diagnostics
indiagnostics.com
